HEADER HORMONE 03-SEP-09 2WS7 TITLE SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN A CHAIN; COMPND 3 CHAIN: A, C, E, G, I, K; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: INSULIN B CHAIN; COMPND 7 CHAIN: B, D, F, H, J, L; COMPND 8 FRAGMENT: RESIDUES 25-50; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606 KEYWDS CARBOHYDRATE METABOLISM, GLUCOSE METABOLISM, HORMONE, ANALOGUE, KEYWDS 2 DIABETES MELLITUS EXPDTA X-RAY DIFFRACTION AUTHOR A.M.BRZOZOWSKI,J.JIRACEK,L.ZAKOVA,E.ANTOLIKOVA,C.J.WATSON, AUTHOR 2 J.P.TURKENBURG,G.G.DODSON REVDAT 5 16-OCT-24 2WS7 1 REMARK REVDAT 4 20-DEC-23 2WS7 1 REMARK LINK REVDAT 3 06-JUN-12 2WS7 1 JRNL REMARK REVDAT 2 13-JUL-11 2WS7 1 VERSN REVDAT 1 09-FEB-10 2WS7 0 JRNL AUTH J.JIRACEK,L.ZAKOVA,E.ANTOLIKOVA,C.J.WATSON,J.P.TURKENBURG, JRNL AUTH 2 G.G.DODSON,A.M.BRZOZOWSKI JRNL TITL IMPLICATIONS FOR THE ACTIVE FORM OF HUMAN INSULIN BASED ON JRNL TITL 2 THE STRUCTURAL CONVERGENCE OF HIGHLY ACTIVE HORMONE JRNL TITL 3 ANALOGUES. JRNL REF PROC.NATL.ACAD.SCI.USA V. 107 1966 2010 JRNL REFN ISSN 0027-8424 JRNL PMID 20133841 JRNL DOI 10.1073/PNAS.0911785107 REMARK 2 REMARK 2 RESOLUTION. 2.59 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0082 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.59 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 57.26 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 7224 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.332 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 352 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.59 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 REFLECTION IN BIN (WORKING SET) : 416 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 78.96 REMARK 3 BIN R VALUE (WORKING SET) : 0.2460 REMARK 3 BIN FREE R VALUE SET COUNT : 23 REMARK 3 BIN FREE R VALUE : 0.4740 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1961 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 42 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 31.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.92 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.47000 REMARK 3 B22 (A**2) : -0.40000 REMARK 3 B33 (A**2) : 0.87000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.842 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.462 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.308 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 26.892 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.921 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.812 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1977 ; 0.013 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2676 ; 1.475 ; 1.964 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 240 ; 6.515 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 83 ;37.352 ;25.542 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 296 ;19.531 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 1 ; 2.621 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 307 ; 0.117 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1461 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1232 ; 0.688 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1956 ; 1.315 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 745 ; 1.789 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 720 ; 2.999 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 12 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 2 A 21 REMARK 3 RESIDUE RANGE : B 2 B 19 REMARK 3 RESIDUE RANGE : C 1 C 21 REMARK 3 RESIDUE RANGE : D 1 D 23 REMARK 3 RESIDUE RANGE : E 1 E 20 REMARK 3 RESIDUE RANGE : F 1 F 20 REMARK 3 RESIDUE RANGE : G 1 G 21 REMARK 3 RESIDUE RANGE : H 1 H 26 REMARK 3 RESIDUE RANGE : I 1 I 21 REMARK 3 RESIDUE RANGE : J 1 J 21 REMARK 3 RESIDUE RANGE : K 2 K 20 REMARK 3 RESIDUE RANGE : L 2 L 22 REMARK 3 ORIGIN FOR THE GROUP (A): -13.2665 -17.3118 -13.7854 REMARK 3 T TENSOR REMARK 3 T11: 0.0357 T22: 0.0491 REMARK 3 T33: 0.0713 T12: -0.0078 REMARK 3 T13: -0.0194 T23: -0.0060 REMARK 3 L TENSOR REMARK 3 L11: 1.1643 L22: 0.5560 REMARK 3 L33: 0.5607 L12: -0.0054 REMARK 3 L13: -0.1950 L23: -0.1897 REMARK 3 S TENSOR REMARK 3 S11: -0.0289 S12: 0.0766 S13: 0.0388 REMARK 3 S21: 0.0120 S22: 0.0354 S23: 0.0478 REMARK 3 S31: -0.0338 S32: -0.0330 S33: -0.0065 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES RESIDUAL ONLY. FOLLOWING RESIDUES ARE NOT REMARK 3 MODELLED DUE TO DISORDER A1,B20-B26,D24-D26,E21,J22- -J26,K21,L1, REMARK 3 L23-L26. FOLLOWING SIDE CHAINS OCCUPANCIES ARE SET TO ZERO DUE REMARK 3 TO HIGH MOBILITY D17,D21,F1,H21,J4,J17,K4, K5,L22.ATOM RECORD REMARK 3 CONTAINS RESIDUAL B FACTORS ONLY. REMARK 4 REMARK 4 2WS7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-SEP-09. REMARK 100 THE DEPOSITION ID IS D_1290041038. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-DEC-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8726 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7871 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 78.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.15000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 10.50 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1MSO REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5 MM ZN ACETATE,35 MM NA CITRATE,0.7% REMARK 280 PHENOL,).7M NACL,0.3M TRIS PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 31.22550 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.25550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.22550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.25550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DODECAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DODECAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12740 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -233.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F, G, H, I, J, REMARK 350 AND CHAINS: K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH C2003 LIES ON A SPECIAL POSITION. REMARK 375 HOH K2004 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN B, TYR 50 TO PRO REMARK 400 ENGINEERED RESIDUE IN CHAIN D, TYR 50 TO PRO REMARK 400 ENGINEERED RESIDUE IN CHAIN F, TYR 50 TO PRO REMARK 400 ENGINEERED RESIDUE IN CHAIN H, TYR 50 TO PRO REMARK 400 ENGINEERED RESIDUE IN CHAIN J, TYR 50 TO PRO REMARK 400 ENGINEERED RESIDUE IN CHAIN L, TYR 50 TO PRO REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 GLY B 20 REMARK 465 GLU B 21 REMARK 465 ARG B 22 REMARK 465 GLY B 23 REMARK 465 PHE B 24 REMARK 465 PHE B 25 REMARK 465 PRO B 26 REMARK 465 PHE D 24 REMARK 465 PHE D 25 REMARK 465 PRO D 26 REMARK 465 ASN E 21 REMARK 465 GLU F 21 REMARK 465 ARG F 22 REMARK 465 GLY F 23 REMARK 465 PHE F 24 REMARK 465 PHE F 25 REMARK 465 PRO F 26 REMARK 465 ARG J 22 REMARK 465 GLY J 23 REMARK 465 PHE J 24 REMARK 465 PHE J 25 REMARK 465 PRO J 26 REMARK 465 GLY K 1 REMARK 465 ASN K 21 REMARK 465 PHE L 1 REMARK 465 GLY L 23 REMARK 465 PHE L 24 REMARK 465 PHE L 25 REMARK 465 PRO L 26 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 4 CB CG CD OE1 OE2 REMARK 480 TYR A 19 CD1 CD2 CE1 CE2 CZ OH REMARK 480 LEU B 17 CG CD1 CD2 REMARK 480 GLU C 17 CG CD OE1 OE2 REMARK 480 LEU D 17 CG CD1 CD2 REMARK 480 GLU D 21 OE1 OE2 REMARK 480 ARG D 22 CB CG CD NE CZ NH1 NH2 REMARK 480 PHE F 1 CG CD1 CD2 CE1 CE2 CZ REMARK 480 GLU G 4 CG CD OE1 OE2 REMARK 480 GLU H 13 CG CD OE1 OE2 REMARK 480 GLU H 21 CG CD OE1 OE2 REMARK 480 GLN J 4 CD OE1 NE2 REMARK 480 LEU J 17 CG CD1 CD2 REMARK 480 GLU K 4 CB CG CD OE1 OE2 REMARK 480 GLN K 5 CG CD OE1 NE2 REMARK 480 ARG L 22 NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLU C 4 CG2 THR C 8 1.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 4 CA GLU A 4 CB -0.179 REMARK 500 GLU H 13 CG GLU H 13 CD 0.096 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU H 13 CA - CB - CG ANGL. DEV. = 29.3 DEGREES REMARK 500 GLU H 13 CB - CG - CD ANGL. DEV. = 16.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN B 3 -69.02 -7.39 REMARK 500 THR C 8 -70.21 -34.59 REMARK 500 VAL D 2 41.00 -79.10 REMARK 500 GLU D 21 -22.77 80.80 REMARK 500 ARG D 22 66.76 -106.40 REMARK 500 VAL F 2 43.18 -84.43 REMARK 500 PHE H 24 -22.15 -157.51 REMARK 500 VAL J 2 34.44 -86.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1020 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 10 NE2 REMARK 620 2 CL B1021 CL 116.7 REMARK 620 3 HIS F 10 NE2 106.5 111.2 REMARK 620 4 HIS J 10 NE2 106.8 105.9 109.5 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN D1024 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 10 NE2 REMARK 620 2 CL D1025 CL 108.1 REMARK 620 3 HIS H 10 NE2 114.5 98.8 REMARK 620 4 HIS L 10 NE2 113.6 106.9 113.4 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 1020 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN D 1024 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 1021 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL D 1025 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH A 1022 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH C 1022 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH E 1021 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH G 1022 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH I 1022 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH K 1021 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HIT RELATED DB: PDB REMARK 900 INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY GLY (F24G) (NMR, REMARK 900 REPRESENTATIVE PLUS 8 STRUCTURES) REMARK 900 RELATED ID: 2HHO RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-SER, HIS-B10-ASP PRO- REMARK 900 B28-LYS, LYS- B29-PRO, 20 STRUCTURES REMARK 900 RELATED ID: 2C8Q RELATED DB: PDB REMARK 900 INSULINE(1SEC) AND UV LASER EXCITED FLUORESCENCE REMARK 900 RELATED ID: 1TYL RELATED DB: PDB REMARK 900 INSULIN (T3R3) (PH 6.4, 0.75 M NACL) COMPLEXED WITH TWO ZINC IONS REMARK 900 AND TYLENOL ( 4'-HYDROXYACETANILIDE) REMARK 900 RELATED ID: 2C8R RELATED DB: PDB REMARK 900 INSULINE(60SEC) AND UV LASER EXCITED FLUORESCENCE REMARK 900 RELATED ID: 1T1K RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-ALA, REMARK 900 PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES REMARK 900 RELATED ID: 1XDA RELATED DB: PDB REMARK 900 STRUCTURE OF INSULIN REMARK 900 RELATED ID: 1HTV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DESTRIPEPTIDE (B28-B30) INSULIN REMARK 900 RELATED ID: 1MSO RELATED DB: PDB REMARK 900 T6 HUMAN INSULIN AT 1.0 A RESOLUTION REMARK 900 RELATED ID: 1UZ9 RELATED DB: PDB REMARK 900 CRYSTALLOGRAPHIC AND SOLUTION STUDIES OF N- LITHOCHOLYL INSULIN: A REMARK 900 NEW GENERATION OF PROLONGED-ACTING INSULINS. REMARK 900 RELATED ID: 1FUB RELATED DB: PDB REMARK 900 FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION REMARK 900 DATA REMARK 900 RELATED ID: 1TYM RELATED DB: PDB REMARK 900 INSULIN (T3R3) (PH 5.6, 1.0 M NACL) COMPLEXED WITH TWO ZINC IONS REMARK 900 AND TYLENOL ( 4'-HYDROXYACETANILIDE) REMARK 900 RELATED ID: 1HUI RELATED DB: PDB REMARK 900 INSULIN MUTANT (B1, B10, B16, B27)GLU, DES -B30, NMR, 25 STRUCTURES REMARK 900 RELATED ID: 2VK0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS REMARK 900 RELATED ID: 1VKT RELATED DB: PDB REMARK 900 HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES REMARK 900 RELATED ID: 1HLS RELATED DB: PDB REMARK 900 NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16) REMARK 900 RELATED ID: 2CEU RELATED DB: PDB REMARK 900 DESPENTAPEPTIDE INSULIN IN ACETIC ACID (PH 2) REMARK 900 RELATED ID: 1T1Q RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-ABA, REMARK 900 PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1QJ0 RELATED DB: PDB REMARK 900 HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR REMARK 900 RELATED ID: 1MHJ RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: REMARK 900 DES-[PHE(B 25)]; REMARK 900 RELATED ID: 1FU2 RELATED DB: PDB REMARK 900 FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION REMARK 900 DATA REMARK 900 RELATED ID: 1SJT RELATED DB: PDB REMARK 900 MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10) REMARK 900 ASP, PRO(B 28)ASP, NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1QIY RELATED DB: PDB REMARK 900 HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED REMARK 900 WITH PHENOL REMARK 900 RELATED ID: 1IOG RELATED DB: PDB REMARK 900 INSULIN MUTANT A3 GLY,(B1, B10, B16, B27) GLU, DES-B30, NMR, 19 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 2VJZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS REMARK 900 RELATED ID: 1IOH RELATED DB: PDB REMARK 900 INSULIN MUTANT A8 HIS,(B1, B10, B16, B27) GLU, DES-B30, NMR, 26 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 1TRZ RELATED DB: PDB REMARK 900 INSULIN (T3R3) COMPLEX WITH TWO ZINC IONS REMARK 900 RELATED ID: 1EVR RELATED DB: PDB REMARK 900 THE STRUCTURE OF THE RESORCINOL/INSULIN R6 HEXAMER REMARK 900 RELATED ID: 1EV3 RELATED DB: PDB REMARK 900 STRUCTURE OF THE RHOMBOHEDRAL FORM OF THE M-CRESOL/INSULIN R6 REMARK 900 HEXAMER REMARK 900 RELATED ID: 1RWE RELATED DB: PDB REMARK 900 ENHANCING THE ACTIVITY OF INSULIN AT RECEPTOR EDGE: REMARK 900 CRYSTALSTRUCTURE AND PHOTO- CROSS-LINKING OF A8 ANALOGUES REMARK 900 RELATED ID: 1OS4 RELATED DB: PDB REMARK 900 DEHYDRATED T6 HUMAN INSULIN AT 295 K REMARK 900 RELATED ID: 1GUJ RELATED DB: PDB REMARK 900 INSULIN AT PH 2: STRUCTURAL ANALYSIS OF THE CONDITIONS PROMOTING REMARK 900 INSULIN FIBRE FORMATION. REMARK 900 RELATED ID: 1AI0 RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), NMR, 10 STRUCTURES REMARK 900 RELATED ID: 1SF1 RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN UNDER AMYLOIDOGENICCONDITION, 15 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 1JCO RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE MONOMERIC [THR(B27 )->PRO,PRO(B28)->THR] REMARK 900 INSULIN MUTANT (PT INSULIN) REMARK 900 RELATED ID: 1JCA RELATED DB: PDB REMARK 900 NON-STANDARD DESIGN OF UNSTABLE INSULIN ANALOGUES WITHENHANCED REMARK 900 ACTIVITY REMARK 900 RELATED ID: 1ZEG RELATED DB: PDB REMARK 900 STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL REMARK 900 RELATED ID: 1OS3 RELATED DB: PDB REMARK 900 DEHYDRATED T6 HUMAN INSULIN AT 100 K REMARK 900 RELATED ID: 1XGL RELATED DB: PDB REMARK 900 HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES REMARK 900 RELATED ID: 1T0C RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN PROINSULIN C- PEPTIDE REMARK 900 RELATED ID: 1QIZ RELATED DB: PDB REMARK 900 HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED REMARK 900 WITH RESORCINOL REMARK 900 RELATED ID: 1G7B RELATED DB: PDB REMARK 900 1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K REMARK 900 RELATED ID: 2WBY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH REMARK 900 INSULIN REMARK 900 RELATED ID: 2AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1EV6 RELATED DB: PDB REMARK 900 STRUCTURE OF THE MONOCLINIC FORM OF THE M -CRESOL/INSULIN R6 HEXAMER REMARK 900 RELATED ID: 1Q4V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRALANALOGUE: REMARK 900 IMPLICATIONS FOR THE MECHANISM OF RECEPTOR REMARK 900 RELATED ID: 2HH4 RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-D-SER, HIS-B10-ASP REMARK 900 PRO-B28-LYS, LYS -B29-PRO, 20 STRUCTURES REMARK 900 RELATED ID: 2H67 RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B5-ALA, HIS-B10-ASP PRO- REMARK 900 B28-LYS, LYS- B29-PRO, 20 STRUCTURES REMARK 900 RELATED ID: 4AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' GREEN' SUBSTATE, REMARK 900 AVERAGE STRUCTURE REMARK 900 RELATED ID: 1J73 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN UNSTABLE INSULIN ANALOG WITH NATIVEACTIVITY. REMARK 900 RELATED ID: 1K3M RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALA, HIS-B10-ASP, PRO- REMARK 900 B28-LYS, LYS- B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1MHI RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: REMARK 900 S(B 9)D; REMARK 900 RELATED ID: 2WC0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH REMARK 900 IODINATED INSULIN REMARK 900 RELATED ID: 1KMF RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALLO-ILE, HIS-B10-ASP, REMARK 900 PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 2HIU RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC-FREE, 10 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 1XW7 RELATED DB: PDB REMARK 900 DIABETES-ASSOCIATED MUTATIONS IN HUMAN INSULIN : CRYSTALSTRUCTURE REMARK 900 AND PHOTO-CROSS-LINKING STUDIES OF A-CHAINVARIANT INSULIN WAKAYAMA REMARK 900 RELATED ID: 5AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' RED' SUBSTATE, AVERAGE REMARK 900 STRUCTURE REMARK 900 RELATED ID: 1G7A RELATED DB: PDB REMARK 900 1.2 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K REMARK 900 RELATED ID: 1ZNJ RELATED DB: PDB REMARK 900 INSULIN, MONOCLINIC CRYSTAL FORM REMARK 900 RELATED ID: 1ZEH RELATED DB: PDB REMARK 900 STRUCTURE OF INSULIN REMARK 900 RELATED ID: 1HIS RELATED DB: PDB REMARK 900 INSULIN (HUMAN, DES-PENTAPEPTIDE (B 26 - B 30)) (NMR, REMARK 900 REPRESENTATIVE PLUS 14 STRUCTURES) REMARK 900 RELATED ID: 1B9E RELATED DB: PDB REMARK 900 HUMAN INSULIN MUTANT SERB9GLU REMARK 900 RELATED ID: 3AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REFINED AVERAGE STRUCTURE REMARK 900 RELATED ID: 1W8P RELATED DB: PDB REMARK 900 STRUCTURAL PROPERTIES OF THE B25TYR-NME- B26PHE INSULIN MUTANT. REMARK 900 RELATED ID: 1HIQ RELATED DB: PDB REMARK 900 INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY SER (F24S) (NMR, REMARK 900 REPRESENTATIVE PLUS 9 STRUCTURES) REMARK 900 RELATED ID: 1LPH RELATED DB: PDB REMARK 900 LYS(B28)PRO(B29)-HUMAN INSULIN REMARK 900 RELATED ID: 1EFE RELATED DB: PDB REMARK 900 AN ACTIVE MINI-PROINSULIN, M2PI REMARK 900 RELATED ID: 1T1P RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-THR, REMARK 900 PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1A7F RELATED DB: PDB REMARK 900 INSULIN MUTANT B16 GLU, B24 GLY, DES-B30 , NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1BEN RELATED DB: PDB REMARK 900 INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE REMARK 900 RELATED ID: 1LKQ RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-GLY, VAL-A3-GLY, HIS- REMARK 900 B10-ASP, PRO- B28-LYS, LYS-B29-PRO, 20 STRUCTURES REMARK 900 RELATED ID: 2WS0 RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMEALAB26-INSULIN AT PH 7.5 REMARK 900 RELATED ID: 2WS4 RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI IN MONOMER FORM REMARK 900 RELATED ID: 2WS1 RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMETYRB26-INSULIN IN REMARK 900 MONOMER FORM REMARK 900 RELATED ID: 2WS6 RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMETYRB26-INSULIN IN REMARK 900 HEXAMER FORM REMARK 900 RELATED ID: 2WRX RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMEALAB26-INSULIN AT PH 3.0 REMARK 900 RELATED ID: 2WRW RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN D-PROB26-DTI- REMARK 900 NH2 REMARK 900 RELATED ID: 2WRU RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN NMEALAB26- REMARK 900 DTI-NH2 REMARK 900 RELATED ID: 2WRV RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN NMEHISB26- REMARK 900 DTI-NH2 REMARK 999 REMARK 999 SEQUENCE REMARK 999 Y26P MUTATION 27-30 RESIDUES ARE DELETED DBREF 2WS7 A 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 2WS7 B 1 26 UNP P01308 INS_HUMAN 25 50 DBREF 2WS7 C 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 2WS7 D 1 26 UNP P01308 INS_HUMAN 25 50 DBREF 2WS7 E 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 2WS7 F 1 26 UNP P01308 INS_HUMAN 25 50 DBREF 2WS7 G 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 2WS7 H 1 26 UNP P01308 INS_HUMAN 25 50 DBREF 2WS7 I 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 2WS7 J 1 26 UNP P01308 INS_HUMAN 25 50 DBREF 2WS7 K 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 2WS7 L 1 26 UNP P01308 INS_HUMAN 25 50 SEQADV 2WS7 PRO B 26 UNP P01308 TYR 50 ENGINEERED MUTATION SEQADV 2WS7 PRO D 26 UNP P01308 TYR 50 ENGINEERED MUTATION SEQADV 2WS7 PRO F 26 UNP P01308 TYR 50 ENGINEERED MUTATION SEQADV 2WS7 PRO H 26 UNP P01308 TYR 50 ENGINEERED MUTATION SEQADV 2WS7 PRO J 26 UNP P01308 TYR 50 ENGINEERED MUTATION SEQADV 2WS7 PRO L 26 UNP P01308 TYR 50 ENGINEERED MUTATION SEQRES 1 A 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 26 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 B 26 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE PRO SEQRES 1 C 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 C 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 D 26 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 D 26 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE PRO SEQRES 1 E 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 E 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 F 26 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 F 26 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE PRO SEQRES 1 G 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 G 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 H 26 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 H 26 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE PRO SEQRES 1 I 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 I 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 J 26 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 J 26 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE PRO SEQRES 1 K 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 K 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 L 26 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 L 26 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE PRO HET IPH A1022 7 HET ZN B1020 1 HET CL B1021 1 HET IPH C1022 7 HET ZN D1024 1 HET CL D1025 1 HET IPH E1021 7 HET IPH G1022 7 HET IPH I1022 7 HET IPH K1021 7 HETNAM IPH PHENOL HETNAM ZN ZINC ION HETNAM CL CHLORIDE ION FORMUL 13 IPH 6(C6 H6 O) FORMUL 14 ZN 2(ZN 2+) FORMUL 15 CL 2(CL 1-) FORMUL 23 HOH *42(H2 O) HELIX 1 1 ILE A 2 CYS A 7 1 6 HELIX 2 2 SER A 12 TYR A 19 1 8 HELIX 3 3 VAL B 2 CYS B 7 1 6 HELIX 4 4 SER B 9 CYS B 19 1 11 HELIX 5 5 ILE C 2 CYS C 7 1 6 HELIX 6 6 SER C 12 ASN C 18 1 7 HELIX 7 7 VAL D 2 CYS D 7 1 6 HELIX 8 8 SER D 9 CYS D 19 1 11 HELIX 9 9 ILE E 2 CYS E 7 1 6 HELIX 10 10 SER E 12 TYR E 19 1 8 HELIX 11 11 VAL F 2 CYS F 7 1 6 HELIX 12 12 SER F 9 CYS F 19 1 11 HELIX 13 13 ILE G 2 CYS G 7 1 6 HELIX 14 14 SER G 12 ASN G 18 1 7 HELIX 15 15 PHE H 1 CYS H 7 1 7 HELIX 16 16 SER H 9 CYS H 19 1 11 HELIX 17 17 ILE I 2 SER I 9 1 8 HELIX 18 18 SER I 12 ASN I 18 1 7 HELIX 19 19 VAL J 2 CYS J 7 1 6 HELIX 20 20 SER J 9 CYS J 19 1 11 HELIX 21 21 ILE K 2 SER K 9 1 8 HELIX 22 22 SER K 12 GLU K 17 1 6 HELIX 23 23 ASN K 18 CYS K 20 5 3 HELIX 24 24 VAL L 2 CYS L 7 1 6 HELIX 25 25 SER L 9 CYS L 19 1 11 SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.02 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.04 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.03 SSBOND 4 CYS C 6 CYS C 11 1555 1555 2.04 SSBOND 5 CYS C 7 CYS D 7 1555 1555 2.05 SSBOND 6 CYS C 20 CYS D 19 1555 1555 2.06 SSBOND 7 CYS E 6 CYS E 11 1555 1555 2.03 SSBOND 8 CYS E 7 CYS F 7 1555 1555 2.05 SSBOND 9 CYS E 20 CYS F 19 1555 1555 2.04 SSBOND 10 CYS G 6 CYS G 11 1555 1555 2.04 SSBOND 11 CYS G 7 CYS H 7 1555 1555 2.03 SSBOND 12 CYS G 20 CYS H 19 1555 1555 2.04 SSBOND 13 CYS I 6 CYS I 11 1555 1555 2.04 SSBOND 14 CYS I 7 CYS J 7 1555 1555 2.07 SSBOND 15 CYS I 20 CYS J 19 1555 1555 2.04 SSBOND 16 CYS K 6 CYS K 11 1555 1555 2.02 SSBOND 17 CYS K 7 CYS L 7 1555 1555 2.05 SSBOND 18 CYS K 20 CYS L 19 1555 1555 2.05 LINK NE2 HIS B 10 ZN ZN B1020 1555 1555 2.06 LINK ZN ZN B1020 CL CL B1021 1555 1555 2.07 LINK ZN ZN B1020 NE2 HIS F 10 1555 1555 2.03 LINK ZN ZN B1020 NE2 HIS J 10 1555 1555 2.04 LINK NE2 HIS D 10 ZN ZN D1024 1555 1555 2.01 LINK ZN ZN D1024 CL CL D1025 1555 1555 2.09 LINK ZN ZN D1024 NE2 HIS H 10 1555 1555 2.02 LINK ZN ZN D1024 NE2 HIS L 10 1555 1555 1.97 SITE 1 AC1 4 HIS B 10 CL B1021 HIS F 10 HIS J 10 SITE 1 AC2 4 HIS D 10 CL D1025 HIS H 10 HIS L 10 SITE 1 AC3 4 HIS B 10 ZN B1020 HIS F 10 HIS J 10 SITE 1 AC4 4 HIS D 10 ZN D1024 HIS H 10 HIS L 10 SITE 1 AC5 3 CYS A 6 SER A 9 CYS A 11 SITE 1 AC6 4 CYS C 6 ILE C 10 CYS C 11 LEU D 11 SITE 1 AC7 3 CYS E 6 ILE E 10 CYS E 11 SITE 1 AC8 4 HIS D 5 CYS G 6 ILE G 10 CYS G 11 SITE 1 AC9 5 VAL B 2 CYS I 6 SER I 9 CYS I 11 SITE 2 AC9 5 HIS J 10 SITE 1 BC1 4 CYS K 6 ILE K 10 CYS K 11 ALA L 14 CRYST1 62.451 66.511 57.297 90.00 90.00 90.00 P 21 21 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016013 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015035 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017453 0.00000